#integrase inhibitor

Taking meds for four days followed by three days off maintained viral suppression for two years.

However, all integrase inhibitors were associated with similar weight gain.

Switching to an integrase inhibitors is not tied to gain in bad fat, according to recent study.

Resistance to four HIV drug classes is tied to high risk of disease and death.

The antiretroviral drug class includes bictegravir, dolutegravir, elvitegravir and raltegravir.

A study looked at the fat composition of people who switched their antiretrovirals to include an integrase inhibitor.

This may reflect loss of the weight-suppressing effect of the older version of the drug.

Aging with HIV won’t slow down Robert Gillum.

HIV advocate Lepena Reid confronts weight gain.

Some HIV meds are linked to weight gain, but we don’t yet know why.

Researchers are surprised and concerned that a strain of HIV that is so broadly resistant to treatment even has the capacity to transmit.

Researchers looked at potential drug-drug interactions among Swiss people with HIV and compared them with a cohort from 2008.

People who switched from tenofovir disoproxil fumarate to tenofovir alafenamide gained weight regardless of other meds.